Final Reminder: Last Chance to Register for FDA | MHRA | HC Joint Symposium on Regulatory Perspectives in Good Clinical Practice, Bioequivalence and Good Pharmacovigilance Practice

This email was sent to Esdek@podam.pl using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo